165 related articles for article (PubMed ID: 36262534)
1. Constitution of mucosa-associated microbiota in the lower digestive tract does not change in early stage of non-alcoholic fatty liver disease with fecal dysbiosis.
Asaji N; Inoue J; Hayashi H; Tokunaga E; Shimamoto Y; Kinoshita M; Tanaka T; Sakai A; Yano Y; Ueda Y; Kodama Y
JGH Open; 2022 Oct; 6(10):677-684. PubMed ID: 36262534
[TBL] [Abstract][Full Text] [Related]
2. Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients.
Midori Y; Nosaka T; Hiramatsu K; Akazawa Y; Tanaka T; Takahashi K; Naito T; Matsuda H; Ohtani M; Nakamoto Y
Front Cell Infect Microbiol; 2024; 14():1371429. PubMed ID: 38650735
[TBL] [Abstract][Full Text] [Related]
3. Mucosa-Associated Microbiota Dysbiosis in the Terminal Ileum Correlates With Bowel Symptoms in Diarrhea-Predominant Irritable Bowel Syndrome.
Wu BY; Xu P; Cheng L; Wang QQ; Qiu HY; Yan XJ; Chen SL
Clin Transl Gastroenterol; 2024 Feb; 15(2):e00658. PubMed ID: 37937852
[TBL] [Abstract][Full Text] [Related]
4. Mucosa-Associated Microbiota in Patients with Irritable Bowel Syndrome: A Comparison of Subtypes.
Matsumoto H; Shiotani A; Katsumata R; Fukushima S; Handa Y; Osawa M; Murao T; Handa O; Umegaki E; Inoue R; Naito Y
Digestion; 2021; 102(1):49-56. PubMed ID: 33271532
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
[TBL] [Abstract][Full Text] [Related]
7. Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease.
Delik A; Dinçer S; Ülger Y; Akkız H; Karaoğullarından Ü
Gene; 2022 Jul; 833():146587. PubMed ID: 35598686
[TBL] [Abstract][Full Text] [Related]
8. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals.
Ringel Y; Maharshak N; Ringel-Kulka T; Wolber EA; Sartor RB; Carroll IM
Gut Microbes; 2015; 6(3):173-81. PubMed ID: 25915459
[TBL] [Abstract][Full Text] [Related]
9. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity.
Nistal E; Sáenz de Miera LE; Ballesteros Pomar M; Sánchez-Campos S; García-Mediavilla MV; Álvarez-Cuenllas B; Linares P; Olcoz JL; Arias-Loste MT; García-Lobo JM; Crespo J; González-Gallego J; Jorquera Plaza F
Rev Esp Enferm Dig; 2019 Apr; 111(4):275-282. PubMed ID: 30810328
[TBL] [Abstract][Full Text] [Related]
10. Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review.
Mohammadi Z; Poustchi H; Motamed-Gorji N; Eghtesad S; Hekmatdoost A; Saniee P; Merat S
Arch Iran Med; 2020 Jan; 23(1):44-52. PubMed ID: 31910634
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of intestinal microbiota in C57BL/6 mice with non-alcoholic fatty liver induced by high-fat diet.
Yan G; Li S; Wen Y; Luo Y; Huang J; Chen B; Lv S; Chen L; He L; He M; Yang Q; Yu Z; Xiao W; Tang Y; Li W; Han J; Zhao F; Yu S; Kong F; Abbasi B; Yin H; Gu C
Front Microbiol; 2022; 13():1051200. PubMed ID: 36620001
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota in Patients with Non-Alcoholic Fatty Liver Disease without Type 2 Diabetes: Stratified by Body Mass Index.
Chuaypen N; Asumpinawong A; Sawangsri P; Khamjerm J; Iadsee N; Jinato T; Sutheeworapong S; Udomsawaengsup S; Tangkijvanich P
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339096
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
Tsai MC; Liu YY; Lin CC; Wang CC; Wu YJ; Yong CC; Chen KD; Chuah SK; Yao CC; Huang PY; Chen CH; Hu TH; Chen CL
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204538
[TBL] [Abstract][Full Text] [Related]
14. Mucosa-Associated Microbial Profile Is Altered in Small Intestinal Bacterial Overgrowth.
Li J; Zhang R; Ma J; Tang S; Li Y; Li Y; Wan J
Front Microbiol; 2021; 12():710940. PubMed ID: 34421869
[TBL] [Abstract][Full Text] [Related]
15. The Features of Fecal and Ileal Mucosa-Associated Microbiota in Dairy Calves during Early Infection with Mycobacterium avium Subspecies paratuberculosis.
Derakhshani H; De Buck J; Mortier R; Barkema HW; Krause DO; Khafipour E
Front Microbiol; 2016; 7():426. PubMed ID: 27065983
[TBL] [Abstract][Full Text] [Related]
16. Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease.
Wang B; Jiang X; Cao M; Ge J; Bao Q; Tang L; Chen Y; Li L
Sci Rep; 2016 Aug; 6():32002. PubMed ID: 27550547
[TBL] [Abstract][Full Text] [Related]
17. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
Boursier J; Mueller O; Barret M; Machado M; Fizanne L; Araujo-Perez F; Guy CD; Seed PC; Rawls JF; David LA; Hunault G; Oberti F; Calès P; Diehl AM
Hepatology; 2016 Mar; 63(3):764-75. PubMed ID: 26600078
[TBL] [Abstract][Full Text] [Related]
18. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
[TBL] [Abstract][Full Text] [Related]
19. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
20. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of
Wang T; Ishikawa T; Sasaki M; Chiba T
Front Med (Lausanne); 2022; 9():822190. PubMed ID: 35308549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
